Lindbrook Capital’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,050
Closed -$4.58K 2920
2023
Q1
$4.58K Hold
3,050
﹤0.01% 1888
2022
Q4
$3.05K Hold
3,050
﹤0.01% 2046
2022
Q3
$5K Hold
3,050
﹤0.01% 1712
2022
Q2
$9K Hold
3,050
﹤0.01% 1326
2022
Q1
$8K Hold
3,050
﹤0.01% 1418
2021
Q4
$14K Buy
+3,050
New +$14K ﹤0.01% 1155